Long-term follow-up of patients with complex coronary artery disease treated with minimally invasive direct coronary artery bypass
CONCLUSIONS: Minimally invasive coronary artery bypass procedures are low-risk surgical procedures. If hybrid procedures have been planned, completion of revascularization should be a major goal.PMID:37964645 | DOI:10.5603/cj.94716 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Sandra Fraund-Cremer Grischa Hoffmann Juliane Arndt Christoph Borzikowsky Katharina Huenges Alexander Thiem Assad Haneya Bernd Panholzer Tim Attmann Johannes Duemmler Jochen Cremer Christina Grothusen Source Type: research
Hemo-metabolic impairment in patients with ST-segment elevation myocardial infarction: Data from the INTERSTELLAR registry
CONCLUSIONS: Hemo-metabolic impairment is significantly associated with increased risk of in-hospital and 1-year mortality in patients with STEMI. It remains a significant prognostic factor, regardless of DTB time.PMID:37964646 | DOI:10.5603/cj.93926 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Min Gyu Kong Jon Suh Bora Lee Hyun Woo Park Su Yeong Park Inki Moon Hyung Oh Choi Hye-Sun Seo Yoon Haeng Cho Nae-Hee Lee Ho-Jun Jang Tae-Hoon Kim Sung Woo Kwon Sang-Don Park Pyung Chun Oh Jeonggeun Moon Kyounghoon Lee Woong Chol Kang Source Type: research
Diagnostic accuracy of a novel optical coherence tomography-based fractional flow reserve algorithm for assessment of coronary stenosis significance
CONCLUSIONS: This clinical study shows the efficiency and accuracy of AccuFFRoct for clinical implementation when using invasive FFR measurement as a reference. It could provide important insights into coronary imaging superior to current methods based on the degree of coronary artery stenosis.PMID:37964647 | DOI:10.5603/cj.90744 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Weili Pan Wenjuan Wei Yumeng Hu Li Feng Yongkui Ren Xinsheng Li Changling Li Jun Jiang Jianping Xiang Xiaochang Leng Da Yin Source Type: research
Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis
CONCLUSIONS: These findings suggest that bivalirudin use during PCI reduced the risk of NACE and all-cause death but did not reduce the risk of MACE compared with heparin use in PCI. More studies specifically designed for anticoagulation strategies and a personalized anticoagulation regimen to comprehensively balance bleeding and ischemia risks are required.PMID:37964648 | DOI:10.5603/cj.90956 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Junyan Zhang Zhongxiu Chen Duolao Wang Chen Li Fangbo Luo Yong He Source Type: research
Cangrelor - Expanding therapeutic options in patients with acute coronary syndrome
Cardiol J. 2023 Nov 15. doi: 10.5603/cj.96076. Online ahead of print.ABSTRACTCangrelor is the only intravenous P2Y12 receptor antagonist. It is an adenosine triphosphate analog that selectively, directly, and reversibly binds to the platelet P2Y12 receptors exerting its antiaggregatory effect. Cangrelor is characterized by linear, dose-dependent pharmacokinetics and rapid onset of action providing potent platelet inhibition exceeding 90%. Cangrelor is rapidly metabolized by endothelial endonucleotidase; thus, its half-life is 2.9 to 5.5 min, and its antiplatelet effect subsides within 60 to 90 min. Data originating from th...
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Jacek Kubica Piotr Adamski S ławomir Dobrzycki Robert Gajda Mariusz G ąsior Marek Gierlotka Mi łosz Jaguszewski Jacek Legutko Maciej Lesiak Eliano Pio Navarese Piotr Niezgoda Ma łgorzata Ostrowska Tomasz Paw łowski Agnieszka Tyci ńska Julia M Umi ń Source Type: research
Long-term follow-up of patients with complex coronary artery disease treated with minimally invasive direct coronary artery bypass
CONCLUSIONS: Minimally invasive coronary artery bypass procedures are low-risk surgical procedures. If hybrid procedures have been planned, completion of revascularization should be a major goal.PMID:37964645 | DOI:10.5603/cj.94716 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Sandra Fraund-Cremer Grischa Hoffmann Juliane Arndt Christoph Borzikowsky Katharina Huenges Alexander Thiem Assad Haneya Bernd Panholzer Tim Attmann Johannes Duemmler Jochen Cremer Christina Grothusen Source Type: research
Hemo-metabolic impairment in patients with ST-segment elevation myocardial infarction: Data from the INTERSTELLAR registry
CONCLUSIONS: Hemo-metabolic impairment is significantly associated with increased risk of in-hospital and 1-year mortality in patients with STEMI. It remains a significant prognostic factor, regardless of DTB time.PMID:37964646 | DOI:10.5603/cj.93926 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Min Gyu Kong Jon Suh Bora Lee Hyun Woo Park Su Yeong Park Inki Moon Hyung Oh Choi Hye-Sun Seo Yoon Haeng Cho Nae-Hee Lee Ho-Jun Jang Tae-Hoon Kim Sung Woo Kwon Sang-Don Park Pyung Chun Oh Jeonggeun Moon Kyounghoon Lee Woong Chol Kang Source Type: research
Diagnostic accuracy of a novel optical coherence tomography-based fractional flow reserve algorithm for assessment of coronary stenosis significance
CONCLUSIONS: This clinical study shows the efficiency and accuracy of AccuFFRoct for clinical implementation when using invasive FFR measurement as a reference. It could provide important insights into coronary imaging superior to current methods based on the degree of coronary artery stenosis.PMID:37964647 | DOI:10.5603/cj.90744 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Weili Pan Wenjuan Wei Yumeng Hu Li Feng Yongkui Ren Xinsheng Li Changling Li Jun Jiang Jianping Xiang Xiaochang Leng Da Yin Source Type: research
Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis
CONCLUSIONS: These findings suggest that bivalirudin use during PCI reduced the risk of NACE and all-cause death but did not reduce the risk of MACE compared with heparin use in PCI. More studies specifically designed for anticoagulation strategies and a personalized anticoagulation regimen to comprehensively balance bleeding and ischemia risks are required.PMID:37964648 | DOI:10.5603/cj.90956 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Junyan Zhang Zhongxiu Chen Duolao Wang Chen Li Fangbo Luo Yong He Source Type: research
Cangrelor - Expanding therapeutic options in patients with acute coronary syndrome
Cardiol J. 2023 Nov 15. doi: 10.5603/cj.96076. Online ahead of print.ABSTRACTCangrelor is the only intravenous P2Y12 receptor antagonist. It is an adenosine triphosphate analog that selectively, directly, and reversibly binds to the platelet P2Y12 receptors exerting its antiaggregatory effect. Cangrelor is characterized by linear, dose-dependent pharmacokinetics and rapid onset of action providing potent platelet inhibition exceeding 90%. Cangrelor is rapidly metabolized by endothelial endonucleotidase; thus, its half-life is 2.9 to 5.5 min, and its antiplatelet effect subsides within 60 to 90 min. Data originating from th...
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Jacek Kubica Piotr Adamski S ławomir Dobrzycki Robert Gajda Mariusz G ąsior Marek Gierlotka Mi łosz Jaguszewski Jacek Legutko Maciej Lesiak Eliano Pio Navarese Piotr Niezgoda Ma łgorzata Ostrowska Tomasz Paw łowski Agnieszka Tyci ńska Julia M Umi ń Source Type: research
Long-term follow-up of patients with complex coronary artery disease treated with minimally invasive direct coronary artery bypass
CONCLUSIONS: Minimally invasive coronary artery bypass procedures are low-risk surgical procedures. If hybrid procedures have been planned, completion of revascularization should be a major goal.PMID:37964645 | DOI:10.5603/cj.94716 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Sandra Fraund-Cremer Grischa Hoffmann Juliane Arndt Christoph Borzikowsky Katharina Huenges Alexander Thiem Assad Haneya Bernd Panholzer Tim Attmann Johannes Duemmler Jochen Cremer Christina Grothusen Source Type: research
Hemo-metabolic impairment in patients with ST-segment elevation myocardial infarction: Data from the INTERSTELLAR registry
CONCLUSIONS: Hemo-metabolic impairment is significantly associated with increased risk of in-hospital and 1-year mortality in patients with STEMI. It remains a significant prognostic factor, regardless of DTB time.PMID:37964646 | DOI:10.5603/cj.93926 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Min Gyu Kong Jon Suh Bora Lee Hyun Woo Park Su Yeong Park Inki Moon Hyung Oh Choi Hye-Sun Seo Yoon Haeng Cho Nae-Hee Lee Ho-Jun Jang Tae-Hoon Kim Sung Woo Kwon Sang-Don Park Pyung Chun Oh Jeonggeun Moon Kyounghoon Lee Woong Chol Kang Source Type: research
Diagnostic accuracy of a novel optical coherence tomography-based fractional flow reserve algorithm for assessment of coronary stenosis significance
CONCLUSIONS: This clinical study shows the efficiency and accuracy of AccuFFRoct for clinical implementation when using invasive FFR measurement as a reference. It could provide important insights into coronary imaging superior to current methods based on the degree of coronary artery stenosis.PMID:37964647 | DOI:10.5603/cj.90744 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Weili Pan Wenjuan Wei Yumeng Hu Li Feng Yongkui Ren Xinsheng Li Changling Li Jun Jiang Jianping Xiang Xiaochang Leng Da Yin Source Type: research
Bivalirudin versus heparin in contemporary percutaneous coronary interventions for patients with acute coronary syndrome: a systematic review and meta-analysis
CONCLUSIONS: These findings suggest that bivalirudin use during PCI reduced the risk of NACE and all-cause death but did not reduce the risk of MACE compared with heparin use in PCI. More studies specifically designed for anticoagulation strategies and a personalized anticoagulation regimen to comprehensively balance bleeding and ischemia risks are required.PMID:37964648 | DOI:10.5603/cj.90956 (Source: Cardiology Journal)
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Junyan Zhang Zhongxiu Chen Duolao Wang Chen Li Fangbo Luo Yong He Source Type: research
Cangrelor - Expanding therapeutic options in patients with acute coronary syndrome
Cardiol J. 2023 Nov 15. doi: 10.5603/cj.96076. Online ahead of print.ABSTRACTCangrelor is the only intravenous P2Y12 receptor antagonist. It is an adenosine triphosphate analog that selectively, directly, and reversibly binds to the platelet P2Y12 receptors exerting its antiaggregatory effect. Cangrelor is characterized by linear, dose-dependent pharmacokinetics and rapid onset of action providing potent platelet inhibition exceeding 90%. Cangrelor is rapidly metabolized by endothelial endonucleotidase; thus, its half-life is 2.9 to 5.5 min, and its antiplatelet effect subsides within 60 to 90 min. Data originating from th...
Source: Cardiology Journal - November 15, 2023 Category: Cardiology Authors: Jacek Kubica Piotr Adamski S ławomir Dobrzycki Robert Gajda Mariusz G ąsior Marek Gierlotka Mi łosz Jaguszewski Jacek Legutko Maciej Lesiak Eliano Pio Navarese Piotr Niezgoda Ma łgorzata Ostrowska Tomasz Paw łowski Agnieszka Tyci ńska Julia M Umi ń Source Type: research
